A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma
2011 ◽
Vol 29
(7)
◽
pp. 451-455
◽
2007 ◽
Vol 13
(15)
◽
pp. 4538-4546
◽
2009 ◽
Vol 7
(2)
◽
pp. 437-438
◽